Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (248 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 07 Mar 2024 – 20 Aug 2026, limited by Kotak Technology Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Kotak Technology Fund | Nifty 500 |
|---|---|---|
| 07 Mar 2024 | ₹100.00 | ₹100.00 |
| 21 May 2024 | ₹98.03 | ₹103.68 |
| 03 Aug 2024 | ₹117.47 | ₹113.82 |
| 17 Oct 2024 | ₹127.56 | ₹114.40 |
| 31 Dec 2024 | ₹125.45 | ₹109.50 |
| 15 Mar 2025 | ₹105.89 | ₹98.73 |
| 29 May 2025 | ₹113.72 | ₹111.87 |
| 12 Aug 2025 | ₹110.14 | ₹110.44 |
| 25 Oct 2025 | ₹115.02 | ₹115.91 |
| 08 Jan 2026 | ₹117.40 | ₹115.88 |
| 24 Mar 2026 | ₹96.10 | ₹103.09 |
| 06 Jun 2026 | ₹96.29 | ₹109.94 |
| 20 Aug 2026 | ₹106.13 | ₹115.06 |
| Metric | Kotak Mahindra · Regular · IDCW NAV ₹10.63 Very High risk ★☆☆☆☆ 1Y | Category median Sectoral/ Thematic · 248 funds |
|---|---|---|
| -7.19% | +3.54% | |
| — | +11.47% | |
| — | +9.70% | |
| — | +10.32% | |
| +2.45% | +9.15% | |
| -2.99% | — | |
| — | +12.10% | |
| — | +10.32% | |
| — | +8.80% | |
| Risk | ||
| 17.09% | 15.91% | |
| -0.80 | 0.25 | |
| -1.13 | 0.32 | |
| -30.19% | -26.14% | |
| Nifty 500 | — | |
| — | -0.04% | |
| — | 0.98 | |
| — | 98.3% | |
| — | 101.5% | |
| 2.52% | 2.38% | |
| ₹524.84Cr | ₹1,160Cr | |
| Up to 0.50% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 21% | 42% | |
| Abhishek Bisen | — | |
| 07 Mar 2024 | — | |
| 22 | — | |
| 71.2% | — | |
| 4.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.